Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedVersion 53 (v3.5.4) was released on 2026-05-13. It adds Contacts/Locations and Study Status sections to the study record history.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, reflecting a backend or platform update rather than a change to the clinical trial record information.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Record History and Study Record Versions with version-by-version details and a compare option, plus related UI elements (Results Posted, Researcher View, Study Details, Download, Save) to improve traceability of the trial record.SummaryDifference39%

- Check84 days agoChange DetectedRevision: v3.4.3 added; several history-related sections appear removed or hidden, with updated UI for versioning.SummaryDifference14%

- Check91 days agoChange DetectedA new Study Status entry was added on 2026-02-10 and an earlier entry was removed on 2025-11-10 in the record history.SummaryDifference0.2%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.